In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 36,830 followers.

RT @RoyalPapLib: #papworthauthors new publication: In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement In…

RT @RoyalPapLib: #papworthauthors new publication: In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement In…

#papworthauthors new publication: In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. https://t.co/nvOv4pyuZ0 #graftTreatment #transplantati

RT @FPoppelaars: Great work by the Atkinson group! These targeted complement inhibitors are the future... #complementbiology #transplantati…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.